Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dale P Conner

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
The AAPS Journal|September 15, 2012
Use of partial area under the curve metrics to assess bioequivalence of methylphenidate multiphasic modified release formulationsEthan M Stier, Barbara M Davit, Parthapratim Chandaroy, et al.
The AAPS Journal|October 12, 2012
Common reasons for "for-cause" inspections in bioequivalence studies submitted to the Food and Drug AdministrationBing V Li, Barbara M Davit, Christina H Lee, et al.
Pharmaceutical Research|August 16, 2002
Biopharmaceutics classification system: the scientific basis for biowaiver extensionsLawrence X Yu, Gordon L Amidon, James E Polli, et al.
The AAPS Journal|March 12, 2015
International Guidelines for Bioequivalence of Locally Acting Orally Inhaled Drug Products: Similarities and DifferencesDongmei Lu, Sau L Lee, Robert A Lionberger, et al.
Molecular Pharmaceutics|October 28, 2017
Impact of the US FDA "Biopharmaceutics Classification System" (BCS) Guidance on Global Drug DevelopmentMehul U Mehta, Ramana S Uppoor, Dale P Conner, et al.
The AAPS Journal|September 14, 2012
Implementation of a reference-scaled average bioequivalence approach for highly variable generic drug products by the US Food and Drug AdministrationBarbara M Davit, Mei-Ling Chen, Dale P Conner, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|February 6, 2010
Demonstrating Bioequivalence of Locally Acting Orally Inhaled Drug Products (OIPs): Workshop Summary ReportWallace P Adams, Richard C Ahrens, Mei-Ling Chen, et al.
Journal of Pharmaceutical Sciences|May 5, 2004
Summary workshop report: biopharmaceutics classification system--implementation challenges and extension opportunitiesJames E Polli, Lawrence X Yu, Jack A Cook, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
The AAPS Journal|September 15, 2012
Use of partial area under the curve metrics to assess bioequivalence of methylphenidate multiphasic modified release formulationsEthan M Stier, Barbara M Davit, Parthapratim Chandaroy, et al.
The AAPS Journal|October 12, 2012
Common reasons for "for-cause" inspections in bioequivalence studies submitted to the Food and Drug AdministrationBing V Li, Barbara M Davit, Christina H Lee, et al.
Pharmaceutical Research|August 16, 2002
Biopharmaceutics classification system: the scientific basis for biowaiver extensionsLawrence X Yu, Gordon L Amidon, James E Polli, et al.
The AAPS Journal|March 12, 2015
International Guidelines for Bioequivalence of Locally Acting Orally Inhaled Drug Products: Similarities and DifferencesDongmei Lu, Sau L Lee, Robert A Lionberger, et al.
Molecular Pharmaceutics|October 28, 2017
Impact of the US FDA "Biopharmaceutics Classification System" (BCS) Guidance on Global Drug DevelopmentMehul U Mehta, Ramana S Uppoor, Dale P Conner, et al.
The AAPS Journal|September 14, 2012
Implementation of a reference-scaled average bioequivalence approach for highly variable generic drug products by the US Food and Drug AdministrationBarbara M Davit, Mei-Ling Chen, Dale P Conner, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|February 6, 2010
Demonstrating Bioequivalence of Locally Acting Orally Inhaled Drug Products (OIPs): Workshop Summary ReportWallace P Adams, Richard C Ahrens, Mei-Ling Chen, et al.
Journal of Pharmaceutical Sciences|May 5, 2004
Summary workshop report: biopharmaceutics classification system--implementation challenges and extension opportunitiesJames E Polli, Lawrence X Yu, Jack A Cook, et al.
Pageof 3